SOPHiA GENETICS (SOPH) Equity Ratio (2020 - 2025)

SOPHiA GENETICS has disclosed Equity Ratio across 6 years of filings, most recently posting 0.48 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.48, down 20.42% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.48 (down 20.42% YoY), and the FY2025 annual result was 0.48, down 20.42% from the prior year.
• Equity Ratio came in at 0.48 for Q4 2025 at SOPHiA GENETICS, down from 0.37 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.22 in Q2 2025 to a low of 0.48 in Q4 2025.
• The 5-year median for Equity Ratio is 0.23 (2021), against an average of 0.16.
• Peak annual rise in Equity Ratio reached 160.62% in 2022, while the deepest fall reached 87.77% in 2022.
• SOPHiA GENETICS's Equity Ratio stood at 0.23 in 2021, then tumbled by 55.85% to 0.36 in 2022, then fell by 6.83% to 0.38 in 2023, then dropped by 5.03% to 0.4 in 2024, then slipped by 20.42% to 0.48 in 2025.
• The last three Equity Ratio figures came in at 0.48 (Q4 2025), 0.37 (Q3 2025), and 0.22 (Q2 2025), per Business Quant data.